A detailed history of Newbridge Financial Services Group, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 468 shares of JAZZ stock, worth $57,549. This represents 0.02% of its overall portfolio holdings.

Number of Shares
468
Previous 468 -0.0%
Holding current value
$57,549
Previous $49,000 6.12%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 28, 2024

BUY
$114.26 - $136.0 $38,391 - $45,696
336 Added 254.55%
468 $57,000
Q4 2021

Jan 19, 2022

SELL
$119.87 - $145.67 $719 - $874
-6 Reduced 4.35%
132 $17,000
Q3 2021

Oct 27, 2021

BUY
$128.64 - $184.79 $771 - $1,108
6 Added 4.55%
138 $18,000
Q2 2021

Sep 07, 2021

BUY
$160.2 - $186.42 $18,583 - $21,624
116 Added 725.0%
132 $23,000
Q1 2021

Sep 07, 2021

BUY
$150.19 - $173.5 $2,403 - $2,776
16 New
16 $3,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.